2026-2030年全球可生物分解醫用塑膠市場

全球可生物分解醫用塑膠市場預計將從 2025 年到 2030 年成長至 7.677 億美元，預測期內複合年成長率為 6.0%。

本報告對全球可生物分解醫用塑膠市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及對約 25 家公司的供應商分析。

本報告對當前市場狀況、最新市場趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場發展的因素包括：對微創手術需求的不斷成長、全球對醫療塑膠廢棄物日益嚴格的監管，以及3D列印和生物可吸收材料工程技術的進步。

本研究客觀地結合了一手和二手訊息，包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告同時呈現了歷史市場規模數據和預測市場規模數據。

這項研究指出，包容性和易用性包裝設計的重要性日益凸顯，這將成為未來幾年全球可生物分解醫用塑膠市場成長的主要驅動力之一。此外，刺激響應型智慧水凝膠系統的開發以及在地化和分散式製造基礎設施的擴展也將產生可觀的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球可生物分解醫用塑膠市場
• 基於應用領域的細分市場分析，2020-2024 年
• 按類型分類的細分市場分析，2020-2024 年
• 2020-2024年基於材料的細分市場分析
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球可生物分解醫用塑膠市場
• 地緣政治衝突的影響：全球可生物分解醫用塑膠市場。

第7章：五力分析

第8章 市場區隔：依應用領域

• 比較：透過應用
• 醫療器材
• 醫療包裝
• 其他
• 市場機會：依應用領域分類

第9章 市場細分：依類型

• 比較：按類型
• 聚乳酸
• 聚羥基烷酯
• 聚丁二酸丁二醇酯
• 聚己內酯
• 聚乙烯醇
• 市場機會：按類型分類

第10章 市場區隔：依材料

• 對比：按材料
• 天然材質
• 合成
• 混合
• 市場機會：依材料分類

第11章 客戶情況

第12章 區域情勢

• 區域分類
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 新加坡
• 中東和非洲
  • 沙烏地阿拉伯
  • UAE
  • 南非
  • 埃及
  • 以色列
• 南美洲
  • 巴西
  • 阿根廷
  • 哥倫比亞
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Ashland Inc.
• Bezwada Biomedical LLC
• Biomedical Polymers Inc.
• Corbion NV
• DSM Firmenich AG
• Evonik Industries AG
• Foryou Medical
• Foster Corp.
• Gebruder Martin GmbH and Co.
• Kaneka Corp.
• NatureWorks LLC
• Polysciences Inc.
• REVA Medical Inc.
• SEQENS GROUP
• Teijin Ltd.

第16章附錄

The global biodegradable medical plastics market is forecasted to grow by USD 767.7 mn during 2025-2030, accelerating at a CAGR of 6.0% during the forecast period. The report on the global biodegradable medical plastics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for minimally invasive surgeries, stringent global regulations against medical plastic waste, technological advancements in 3d printing and bio resorbable material engineering.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global biodegradable medical plastics market is segmented as below:

By Application

• Medical devices
• Medical packaging
• Others

By Type

• Poly lactic acid
• Polyhydroxyalkanoates
• Polybutylene succinate
• Polycaprolactone
• Polyvinyl alcohol

By Material

• Natural
• Synthetic
• Hybrid

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore
• Middle East and Africa
  • UAE
  • South Africa
  • Egypt
• South America
  • Brazil
  • Argentina
  • Colombia
• Rest of World (ROW)

This study identifies the rising importance of inclusive and accessible packaging design as one of the prime reasons driving the global biodegradable medical plastics market growth during the next few years. Also, development of stimuli responsive smart hydrogel systems and expansion of localized and regionalized manufacturing infrastructure will lead to sizable demand in the market.

The report on the global biodegradable medical plastics market covers the following areas:

• Global biodegradable medical plastics market sizing
• Global biodegradable medical plastics market forecast
• Global biodegradable medical plastics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global biodegradable medical plastics market vendors that include 3D Biotek LLC, Ashland Inc., Bezwada Biomedical LLC, Biomedical Polymers Inc., Corbion N.V., DSM Firmenich AG, Evonik Industries AG, Foryou Medical, Foster Corp., Gebruder Martin GmbH and Co., Kaneka Corp., NatureWorks LLC, Nomisma Healthcare Pvt. Ltd., Poly Med Inc., Polysciences Inc., REVA Medical Inc., SEQENS GROUP, Teijin Ltd., Zeus Co. Inc.. Also, the global biodegradable medical plastics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Material
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Biodegradable Medical Plastics Market 2020 - 2024
  • Historic Market Size - Data Table on Global Biodegradable Medical Plastics Market 2020 - 2024 ($ million)
• 5.2 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.3 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.4 Material segment analysis 2020 - 2024
  • Historic Market Size - Material Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global biodegradable medical plastics market
• 6.2 Impact of geopolitical conflicts on global biodegradable medical plastics market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Application

• 8.1 Market segments
• 8.2 Comparison by Application
• 8.3 Medical devices - Market size and forecast 2025-2030
• 8.4 Medical packaging - Market size and forecast 2025-2030
• 8.5 Others - Market size and forecast 2025-2030
• 8.6 Market opportunity by Application
  • Market opportunity by Application ($ million)

9 Market Segmentation by Type

• 9.1 Market segments
• 9.2 Comparison by Type
• 9.3 Poly lactic acid - Market size and forecast 2025-2030
• 9.4 Polyhydroxyalkanoates - Market size and forecast 2025-2030
• 9.5 Polybutylene succinate - Market size and forecast 2025-2030
• 9.6 Polycaprolactone - Market size and forecast 2025-2030
• 9.7 Polyvinyl alcohol - Market size and forecast 2025-2030
• 9.8 Market opportunity by Type
  • Market opportunity by Type ($ million)

10 Market Segmentation by Material

• 10.1 Market segments
• 10.2 Comparison by Material
• 10.3 Natural - Market size and forecast 2025-2030
• 10.4 Synthetic - Market size and forecast 2025-2030
• 10.5 Hybrid - Market size and forecast 2025-2030
• 10.6 Market opportunity by Material
  • Market opportunity by Material ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 APAC - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Australia - Market size and forecast 2025-2030
  • 12.5.6 Singapore - Market size and forecast 2025-2030
• 12.6 Middle East and Africa - Market size and forecast 2025-2030
  • 12.6.1 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.2 UAE - Market size and forecast 2025-2030
  • 12.6.3 South Africa - Market size and forecast 2025-2030
  • 12.6.4 Egypt - Market size and forecast 2025-2030
  • 12.6.5 Israel - Market size and forecast 2025-2030
• 12.7 South America - Market size and forecast 2025-2030
  • 12.7.1 Brazil - Market size and forecast 2025-2030
  • 12.7.2 Argentina - Market size and forecast 2025-2030
  • 12.7.3 Colombia - Market size and forecast 2025-2030
• 12.8 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Increasing demand for minimally invasive surgeries
  • Stringent global regulations against medical plastic waste
  • Technological advancements in 3D printing and bio resorbable material engineering
• 13.2 Market challenges
  • Prohibitive production costs and economic disparity
  • Technical limitations in sterilization and material integrity
  • Manufacturing scalability and supply chain volatility
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Rising importance of inclusive and accessible packaging design
  • Development of stimuli responsive smart hydrogel systems
  • Expansion of localized and regionalized manufacturing infrastructure

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Ashland Inc.
  • Ashland Inc. - Overview
  • Ashland Inc. - Business segments
  • Ashland Inc. - Key news
  • Ashland Inc. - Key offerings
  • Ashland Inc. - Segment focus
  • SWOT
• 15.5 Bezwada Biomedical LLC
  • Bezwada Biomedical LLC - Overview
  • Bezwada Biomedical LLC - Product / Service
  • Bezwada Biomedical LLC - Key offerings
  • SWOT
• 15.6 Biomedical Polymers Inc.
  • Biomedical Polymers Inc. - Overview
  • Biomedical Polymers Inc. - Product / Service
  • Biomedical Polymers Inc. - Key offerings
  • SWOT
• 15.7 Corbion N.V.
  • Corbion N.V. - Overview
  • Corbion N.V. - Business segments
  • Corbion N.V. - Key offerings
  • Corbion N.V. - Segment focus
  • SWOT
• 15.8 DSM Firmenich AG
  • DSM Firmenich AG - Overview
  • DSM Firmenich AG - Business segments
  • DSM Firmenich AG - Key offerings
  • DSM Firmenich AG - Segment focus
  • SWOT
• 15.9 Evonik Industries AG
  • Evonik Industries AG - Overview
  • Evonik Industries AG - Business segments
  • Evonik Industries AG - Key offerings
  • Evonik Industries AG - Segment focus
  • SWOT
• 15.10 Foryou Medical
  • Foryou Medical - Overview
  • Foryou Medical - Product / Service
  • Foryou Medical - Key offerings
  • SWOT
• 15.11 Foster Corp.
  • Foster Corp. - Overview
  • Foster Corp. - Product / Service
  • Foster Corp. - Key offerings
  • SWOT
• 15.12 Gebruder Martin GmbH and Co.
  • Gebruder Martin GmbH and Co. - Overview
  • Gebruder Martin GmbH and Co. - Product / Service
  • Gebruder Martin GmbH and Co. - Key offerings
  • SWOT
• 15.13 Kaneka Corp.
  • Kaneka Corp. - Overview
  • Kaneka Corp. - Business segments
  • Kaneka Corp. - Key offerings
  • Kaneka Corp. - Segment focus
  • SWOT
• 15.14 NatureWorks LLC
  • NatureWorks LLC - Overview
  • NatureWorks LLC - Product / Service
  • NatureWorks LLC - Key offerings
  • SWOT
• 15.15 Polysciences Inc.
  • Polysciences Inc. - Overview
  • Polysciences Inc. - Product / Service
  • Polysciences Inc. - Key offerings
  • SWOT
• 15.16 REVA Medical Inc.
  • REVA Medical Inc. - Overview
  • REVA Medical Inc. - Product / Service
  • REVA Medical Inc. - Key offerings
  • SWOT
• 15.17 SEQENS GROUP
  • SEQENS GROUP - Overview
  • SEQENS GROUP - Product / Service
  • SEQENS GROUP - Key offerings
  • SWOT
• 15.18 Teijin Ltd.
  • Teijin Ltd. - Overview
  • Teijin Ltd. - Business segments
  • Teijin Ltd. - Key offerings
  • Teijin Ltd. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations